Nautilus Biotechnology Inc (NAUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 81,476 | 76,152 | 63,618 | 50,498 | 15,744 |
| Operating Income | -81,476 | -76,152 | -63,618 | -50,498 | -15,744 |
| Other Income | 10,696 | 12,477 | 5,694 | 183 | 125 |
| Pre-tax Income | -70,780 | -63,675 | -57,924 | -50,315 | -15,619 |
| Net Income Continuous | -70,780 | -63,675 | -57,924 | -50,315 | -15,619 |
| Net Income | $-70,780 | $-63,675 | $-57,924 | $-50,315 | $-15,619 |
| EPS Basic Total Ops | -0.56 | -0.51 | -0.46 | -0.60 | -0.54 |
| EPS Basic Continuous Ops | -0.56 | -0.51 | -0.46 | -0.60 | -0.54 |
| EPS Diluted Total Ops | -0.56 | -0.51 | -0.46 | -0.60 | -0.54 |
| EPS Diluted Continuous Ops | -0.56 | -0.51 | -0.46 | -0.60 | -0.54 |
| EPS Diluted Before Non-Recurring Items | -0.56 | -0.51 | -0.46 | -0.60 | N/A |
| EBITDA(a) | $-77,927 | $-73,106 | $-61,092 | $-47,473 | $-13,116 |